Tests have shown the VivaGel condom is effective in deactivating 99.9 per cent of HIV, herpes and human papilloma virus cases.
This product is the brainchild of Australian bio-tech firm Starpharma. The product has now received a receipt of Conformity of Assessment Certification by the Australian Therapeutic Goods Administration – a similar certificate to the CE mark in Europe – paving the way for mass production. This means that it could be available to buy in the coming months.
Starpharma has developed the antiviral Viva Gel, the active ingredient designed to tackle sexually transmitted infections, in the condom’s lubricant. And they are working with biggest condom maker in Australia, Ansell.
1. *Stock Images*
2. Tests have shown the gel is effective at deactivating 99.9 per cent of HIV, pictured under the microscope, herpes and human pappilloma virus cases
3. It is hoped the VivaGel will help reduce the transmission of HIV and other STIs, while also reducing the risk of pregnancy